Associations Between Diabetic Retinopathy and Plasma Levels of High-sensitive C-reactive Protein or Von Willebrand Factor in Long-term Type 1 Diabetic Patients

REFERENCES

• Grauslund J, Green A, Sjølie AK. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 2009;52:1829–1835.
   PubMed Web of Science ®Google Scholar
• Grauslund J, Green A, Sjølie AK. Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. Ophthalmology 2009;116:2170–2174.
   PubMed Web of Science ®Google Scholar
• Klein R, Lee KE, Gangnon RE, Klein BE. The 25-year incidence of visual impairment in type 1 diabetes mellitus–the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2010;117:63–70.
   PubMed Web of Science ®Google Scholar
• Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD. EURODIAB Prospective Complications Study Group. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes–the EURODIAB Prospective Complications Study. Diabetologia 2005;48:370–378.
   PubMed Web of Science ®Google Scholar
• Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2009;127:1175–1182.
   PubMed Web of Science ®Google Scholar
• Gustavsson C, Agardh E, Bengtsson B, Agardh CD. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complicat 2008;22:309–316.
   Google Scholar
• Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450–1452.
   PubMed Web of Science ®Google Scholar
• Nowak M, Wielkoszynski T, Marek B, Kos-Kudła B, Swietochowska E, Siemiñska L et al. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin Exp Med 2010;10:185–192.
   Google Scholar
• Izuora KE, Chase HP, Jackson WE, Coll JR, Osberg IM, Gottlieb PA et al. Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care 2005;28:714–715.
   PubMed Web of Science ®Google Scholar
• Chan NN, Fuller JH, Rubens M, Colhoun HM. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Med Sci Monit 2003;9:CR297–CR303.
   Google Scholar
• Stehouwer CD, Zellenrath P, Polak BC, Baarsma GS, Nauta JJ, Donker AJ et al. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 1992;35:555–559.
   PubMed Web of Science ®Google Scholar
• Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM et al. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Diabetologia 1997;40:698–705.
   Google Scholar
• Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 1997;104:252–260.
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M et al. EURODIAB Prospective Complications Study. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001;24:284–289.
   PubMed Web of Science ®Google Scholar
• Green A, Hauge M, Holm NV, Rasch LL. Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 1981;20:468–470.
   PubMed Web of Science ®Google Scholar
• Sjølie AK. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 1985;172:1–77.
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98:786–806.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991;98:823–833.
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92:905–909.
   PubMed Web of Science ®Google Scholar
• Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S, Kuroda A. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002;25:1432–1438.
   PubMed Web of Science ®Google Scholar
• Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD. C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 2002;25:1813–1817.
   Google Scholar
• Shahbazi S, Lenting PJ, Fribourg C, Terraube V, Denis CV, Christophe OD. Characterization of the interaction between von Willebrand factor and osteoprotegerin. J Thromb Haemost 2007;5:1956–1962.
   Google Scholar
• Nybo M, Rasmussen LM. The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review. Eur J Endocrinol 2008;159:603–608.
   PubMed Web of Science ®Google Scholar
• Grauslund J, Rasmussen LM, Green A, Sjølie AK. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? Scand J Clin Lab Invest 2010;70:188–193.
   PubMed Web of Science ®Google Scholar